摘要
目的分析临床分离的肺炎克雷伯菌的分布特点和耐药性状况。方法从临床各科室送检标本中分离出肺炎克雷伯菌,并进行药敏试验,对结果进行分析。结果共分离获得肺炎克雷伯菌415株,分离菌主要分布在神经外科(36.1%)、呼吸内科(27.7%)和重症医学科(16.9%),74.7%来自痰标本。30.0%的分离株为产超广谱β-内酰胺酶(ESBLs)菌株。肺炎克雷伯菌对美罗培南和亚胺培南的耐药率较低,均为0.5%。结论监测肺炎克雷伯菌的耐药趋势对指导临床用药有重要意义。
Objective To analyze the distribution and drug resistance of the isolated strains of Klebsiella pneumonia.MethodsThe strains of Klebsiellapneumonia were isolated from specimens from clinical departments,and the drug resistance was tested.The results were analyzed.Results There were 415 strains of Klebsiella pneumonia were isolated.The isolated strains distributed mainly in Department of Neurosurgery（36.1%）,Department of Respiratory Medicine（27.7%）,and ICU（16.9%）.74.7% of the strains were isolated from sputum specimens.30.0% of the isolated strains were ESBLs positive.The drug resistance rates of Klebsiella pneumonia to meropenem and imipenem were both low to 0.5%.Conclusion Monitoring the drug resistance of Klebsiella pneumoniais very important to guide the treatment.
出处
《国际检验医学杂志》
CAS
2014年第22期3076-3077,共2页
International Journal of Laboratory Medicine
关键词
肺炎克雷伯菌
分布
耐药性
Klebsiella pneumonia
distribution
drug resistance
